Loading clinical trials...
Loading clinical trials...
A Single-blind Randomized Placebo Controlled Pilot Study With Individualized Homeopathic Treatment in the Children With Autism Spectrum Disorder
This study looked at whether homeopathic treatment could help children with Autism Spectrum Disorder (ASD) when used alongside regular therapies like speech and occupational therapy. Over seven years, children between the ages of 2 and 12 were divided into two groups (through computer generated list). One group received individualized homeopathic medicines, and the other received a look-alike placebo (with no active ingredients). Meanwhile, both the groups continued with their regular therapies. Researchers used various tools and parent questionnaires to track the children's progress in areas like communication, behavior, social skills, daily functioning, toilet training and sensory skills. They found that the children who received homeopathic treatment showed more improvement in these areas compared to those who just received only speech / occupational therapies.
Age
3 - 12 years
Sex
ALL
Healthy Volunteers
No
Holistic Homoeopathic Clinic and Research Center
New Delhi, National Capital Territory of Delhi, India
Start Date
January 1, 2017
Primary Completion Date
December 31, 2024
Completion Date
January 15, 2025
Last Updated
July 8, 2025
54
ACTUAL participants
Homoeopathic medicines
DRUG
Placebo
DRUG
THERAPY
BEHAVIORAL
Lead Sponsor
Aditi Chadha
NCT07189442
NCT06878326
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions